Adagene Stock (NASDAQ: ADAG) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 25.442K |
Day Range | - - - |
52 Wk Range | 1.100 - 4.380 |
Market Cap | $103.327M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 40 |
Short Interest | 0.04% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Adagene (NASDAQ: ADAG) through any online brokerage.
Other companies in Adagene’s space includes: Anixa Biosciences (NASDAQ:ANIX), Cellectar Biosciences (NASDAQ:CLRB), Curis (NASDAQ:CRIS), Connect Biopharma Hldgs (NASDAQ:CNTB) and FibroGen (NASDAQ:FGEN).
The latest price target for Adagene (NASDAQ: ADAG) was reported by HC Wainwright & Co. on Wednesday, October 4, 2023. The analyst firm set a price target for 5.00 expecting ADAG to rise to within 12 months (a possible 124.22% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Adagene (NASDAQ: ADAG) is $2.23 last updated May 10, 2024 at 3:57 PM EDT.
There are no upcoming dividends for Adagene.
Adagene’s FY earnings are confirmed for Friday, May 24, 2024.
There is no upcoming split for Adagene.
Adagene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.